Cargando…
Functional Biomarkers for Amyotrophic Lateral Sclerosis
The clinical diagnosis of amyotrophic lateral sclerosis (ALS) relies on determination of progressive dysfunction of both cortical as well as spinal and bulbar motor neurons. However, the variable mix of upper and lower motor neuron signs result in the clinical heterogeneity of patients with ALS, res...
Autores principales: | Huynh, William, Dharmadasa, Thanuja, Vucic, Steve, Kiernan, Matthew C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328463/ https://www.ncbi.nlm.nih.gov/pubmed/30662429 http://dx.doi.org/10.3389/fneur.2018.01141 |
Ejemplares similares
-
Improving clinical trial outcomes in amyotrophic lateral sclerosis
por: Kiernan, Matthew C., et al.
Publicado: (2020) -
Motor cortical excitability predicts cognitive phenotypes in amyotrophic lateral sclerosis
por: Agarwal, Smriti, et al.
Publicado: (2021) -
Cortical inexcitability defines an adverse clinical profile in amyotrophic lateral sclerosis
por: Dharmadasa, T., et al.
Publicado: (2020) -
Study protocol of RESCUE-ALS: A Phase 2, randomised, double-blind, placebo-controlled study in early symptomatic amyotrophic lateral sclerosis patients to assess bioenergetic catalysis with CNM-Au8 as a mechanism to slow disease progression
por: Vucic, Steve, et al.
Publicado: (2021) -
Regional motor cortex dysfunction in amyotrophic lateral sclerosis
por: Menon, Parvathi, et al.
Publicado: (2019)